Cargando…
Mpox multi-antigen mRNA vaccine candidates by a simplified manufacturing strategy afford efficient protection against lethal orthopoxvirus challenge
Current unprecedented mpox outbreaks in non-endemic regions represent a global public health concern. Although two live-attenuated vaccinia virus (VACV)-based vaccines have been urgently approved for people at high risk for mpox, a safer and more effective vaccine that can be available for the gener...
Autores principales: | Zeng, Jiawei, Li, Yao, Jiang, Linrui, Luo, Ling, Wang, Yue, Wang, Hao, Han, Xiaonan, Zhao, Jian, Gu, Guanglei, Fang, Min, Huang, Qingrui, Yan, Jinghua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10167873/ https://www.ncbi.nlm.nih.gov/pubmed/37070521 http://dx.doi.org/10.1080/22221751.2023.2204151 |
Ejemplares similares
-
Novel Orthopoxvirus and Lethal Disease in Cat, Italy
por: Lanave, Gianvito, et al.
Publicado: (2018) -
Extraction-free LAMP assays for generic detection of Old World Orthopoxviruses and specific detection of Mpox virus
por: Li, Zhiru, et al.
Publicado: (2023) -
Rational development of multicomponent mRNA vaccine candidates against mpox
por: Zhang, Rong-Rong, et al.
Publicado: (2023) -
COVID-19 mRNA vaccines
por: Huang, Qingrui, et al.
Publicado: (2021) -
A single cidofovir treatment rescues animals at progressive stages of lethal orthopoxvirus disease
por: Israely, Tomer, et al.
Publicado: (2012)